If you sell peptide active pharmaceutical ingredients (APIs) in Europe, you need to know about the Certificate of Suitability. This document, also called a CEP, proves that your peptide API meets European Pharmacopoeia standards.
Without a CEP, getting your peptide API into the European market becomes much harder. This guide explains everything you need to know.
- A Certificate of Suitability proves your peptide API meets European Pharmacopoeia quality standards for market access.
- Apply through EDQM by preparing a dossier covering synthesis, impurity profiles, analytical methods, and stability data.
- CEPs protect your proprietary manufacturing details while letting drug makers reference your quality credentials.
- Only peptide APIs described in a European Pharmacopoeia monograph are eligible for CEP certification.
- Maintain your CEP through timely revisions whenever you change manufacturing processes, specifications, or production sites.
- A CEP simplifies European regulatory submissions compared to filing a full Drug Master File with each application.
What Is a Certificate of Suitability?
A Certificate of Suitability (CEP) is a document issued by the European Directorate for the Quality of Medicines (EDQM). It shows that the quality of your API is controlled by the European Pharmacopoeia monograph.
In simple terms, a CEP tells regulators that your peptide API meets the quality standards described in European rules. It covers things like how the API is made, tested, and stored.
The CEP system was created to simplify regulatory submissions. Instead of sharing detailed manufacturing information with every drug maker who uses your API, you can just provide your CEP.
Why CEPs Matter for Peptide APIs
Peptide APIs are complex molecules. They are made through multi-step synthesis processes that can introduce impurities.
A CEP shows that you have these processes under control. It gives drug makers and regulators confidence in the quality of your peptide API.
| Benefit | Explanation |
|---|---|
| Market Access | Required for many European marketing applications |
| Confidentiality | Protects proprietary manufacturing details |
| Simplified Submissions | Drug makers reference your CEP instead of full DMF |
| Quality Assurance | Demonstrates compliance with pharmacopoeia standards |
| Competitive Advantage | Sets your API apart from competitors without CEPs |
The EDQM has issued over 4,500 Certificates of Suitability to API manufacturers worldwide, according to data from the European Directorate for the Quality of Medicines. These certificates cover a wide range of chemical and biological substances.
Who Needs a CEP?
Not every peptide API needs a CEP. But if you want to supply your API to drug companies that sell products in Europe, having one is a big advantage.
Drug companies that submit Marketing Authorisation Applications (MAAs) in Europe can reference your CEP. This saves them from having to include all your manufacturing details in their application.
If your peptide API is described in a European Pharmacopoeia monograph, you can apply for a CEP. If there is no monograph for your specific peptide, other regulatory pathways may apply.
How to Apply for a CEP
The application process involves several steps. Let us walk through each one.
Step 1: Check Eligibility
First, confirm that a European Pharmacopoeia monograph exists for your peptide API. You can search the EDQM database to find out.
If a monograph exists, you can proceed with the application. If not, you may need to work with the EDQM to develop one, or use alternative regulatory approaches.
Step 2: Prepare Your Dossier
Your CEP application dossier needs to be thorough. It should cover all aspects of your peptide API's quality.
The dossier follows the Common Technical Document (CTD) format. Specifically, you will need to fill out Module 3 (Quality) sections.
Key Sections of the Dossier
- General information about the API
- Manufacturing process description
- Control of materials (starting materials and reagents)
- Control of critical steps and intermediates
- Process validation data
- Control of the API (specifications and test methods)
- Stability data
- Container closure system
"The level of detail required in a CEP dossier for peptide APIs has increased significantly over the past decade. Regulators now expect comprehensive impurity profiles and robust analytical methods," explains Dr. Klaus Weber, a pharmaceutical quality consultant based in Frankfurt.
Step 3: Submit Your Application
Submit your dossier to the EDQM electronically. You will also need to pay a fee.
The fee depends on the type of substance and whether this is a new application or a revision. Current fees range from about 5,000 to 15,000 euros.
Step 4: EDQM Review
The EDQM will review your dossier. This process can take 6 to 18 months, depending on the complexity of your peptide API and any questions that arise.
During the review, the EDQM may send you deficiency letters asking for more information. Respond to these quickly and completely.
| Application Stage | Typical Timeline |
|---|---|
| Dossier Preparation | 3-6 months |
| EDQM Review | 6-18 months |
| Deficiency Responses | Variable |
| CEP Issuance | After successful review |
| CEP Validity | No expiration (but subject to revisions) |
Step 5: EDQM Inspection
In many cases, the EDQM will inspect your manufacturing facility before granting the CEP. They want to verify that your actual practices match what is in your dossier.
Make sure your facility is inspection-ready. For tips on preparing for regulatory inspections, see our guide on GMP facility audit preparation.
What the Dossier Must Cover for Peptides
Peptide APIs have some unique requirements compared to small molecule APIs. Here are the areas that need extra attention.
Synthesis Process
You need to describe your peptide synthesis process in detail. This includes the starting materials, each coupling step, and all purification steps.
For solid-phase peptide synthesis (SPPS), include details about the resin, coupling reagents, and cleavage conditions. For liquid-phase synthesis, document each reaction step clearly.
Impurity Profile
Peptide APIs can have many types of impurities. These include deletion sequences, truncated sequences, and racemized amino acids.
You need to identify and quantify all significant impurities. Your analytical methods must be able to detect them reliably.
Analytical Methods
Your testing methods need to be validated. Key methods for peptide APIs include HPLC for purity, mass spectrometry for identity, and amino acid analysis for composition.
The EDQM expects your methods to be specific, accurate, and reproducible. Include full validation data in your dossier.
Stability Data
Include stability data showing your peptide API stays within specification over its shelf life. Test under both normal and stress conditions.
Peptides can be sensitive to temperature, humidity, and light. Your stability program should address all these factors.
Maintaining Your CEP
Getting your CEP is not the end of the process. You need to maintain it over time.
Any change to your manufacturing process, specifications, or testing methods may require a CEP revision. You must notify the EDQM of significant changes.
Types of Revisions
- Minor changes: Submit a notification
- Major changes: Submit a revision application
- Critical changes: May require a new evaluation
Keep your CEP up to date. Drug companies relying on your CEP need to know that it reflects your current operations.
CEP vs. Drug Master File
Some people confuse CEPs with Drug Master Files (DMFs). They serve similar purposes but are different documents.
A DMF is submitted to a specific regulatory agency (like the FDA). A CEP is issued by the EDQM and recognized across Europe.
| Feature | CEP | DMF |
|---|---|---|
| Issuing Body | EDQM | Submitted to FDA or other agency |
| Geographic Scope | Europe-wide | Country-specific |
| Review Process | EDQM evaluates quality | Referenced by drug applicant |
| Confidentiality | Manufacturing details protected | Manufacturing details protected |
| Inspection | EDQM may inspect | FDA may inspect |
Common Mistakes in CEP Applications
Many peptide API makers make similar mistakes when applying for a CEP. Avoid these common pitfalls.
- Not providing enough detail about the synthesis process
- Using non-validated analytical methods
- Missing or incomplete impurity data
- Insufficient stability data
- Not following CTD format properly
- Failing to describe container closure systems adequately
Learning from others' mistakes can save you time and money. For more on quality management approaches, check out our article on quality risk management under ICH Q9.
Frequently Asked Questions
How long does it take to get a CEP for a peptide API?
The entire process, from dossier preparation to CEP issuance, typically takes 12 to 24 months. The timeline depends on the complexity of your peptide API, the quality of your dossier, and how quickly you respond to any EDQM questions.
Does a CEP expire?
No, a CEP does not have an expiration date. However, it must be kept up to date. If you make changes to your manufacturing process or specifications without updating your CEP, it can be suspended or withdrawn by the EDQM.
Can a CEP be used outside of Europe?
The CEP is primarily recognized in Europe. However, some regulatory agencies outside Europe may accept a CEP as supporting documentation. It is not a substitute for regulatory filings in countries like the United States, where a DMF is typically required.
How much does a CEP application cost?
The EDQM charges fees ranging from approximately 5,000 to 15,000 euros for new applications. Revision fees are lower. You also need to factor in the cost of preparing the dossier, which may include consulting fees, analytical testing, and stability studies.
What happens if my CEP application is rejected?
If your application is rejected, the EDQM will explain the reasons. You can address the issues and resubmit. Common reasons for rejection include incomplete data, inadequate analytical methods, and insufficient control of impurities. Most rejections can be overcome with additional work.
Can multiple manufacturing sites be covered by one CEP?
Each manufacturing site typically needs its own CEP. However, if the same company has multiple sites performing different steps of the manufacturing process, these can sometimes be covered under one certificate with appropriate documentation.
Final Thoughts
A Certificate of Suitability is a valuable asset for peptide API manufacturers. It opens doors to the European market and demonstrates your commitment to quality.
The application process takes effort, but the benefits are worth it. Start preparing your dossier early, pay attention to the details, and be ready to respond to EDQM questions promptly.
With a CEP in hand, your peptide API will be well positioned for success in the global pharmaceutical market.
Topics
Dr. Lisa Park
Regulatory Affairs Specialist
PharmD | 9 years in peptide pharmaceutical compliance
Focuses on FDA, DEA, and state pharmacy board regulations governing peptide compounds. Guides compounding pharmacies and peptide manufacturers through changing compliance landscapes.
Reviewed by Dr. Lisa Park, PharmD, April 2026